Journal Article Summary

The article investigates the release characteristics of doxazosin mesylate sustained-release tablets, focusing on how their structural properties influence drug release behavior. This topic is significant because understanding the release mechanisms of both brand-name and generic medications can help ensure their effectiveness and safety for patients. Doxazosin mesylate is commonly used to treat conditions like benign prostatic hyperplasia and hypertension, making it essential to evaluate how different formulations perform, especially in the presence of substances like alcohol that can affect drug release.

The study involved comparing the release profiles of a reference listed drug (RLD) and its generic counterpart using micro-computed tomography (micro-CT) to analyze their 3D structures. Both formulations were subjected to standard dissolution tests in various media, including those with different pH levels and ethanol concentrations. The results showed that while the release profiles were similar in conventional tests, the generic formulation released the drug slightly faster in ethanol-containing media, indicating potential differences in how the two formulations respond to alcohol.

Limitations of the study include the specific conditions under which the tests were conducted, which may not fully replicate real-world scenarios. Additionally, while both formulations showed some resistance to dose dumping when exposed to alcohol, the generic version exhibited a higher risk of accelerated release under these conditions. Patients should discuss these findings with their healthcare providers, especially if they consume alcohol while taking doxazosin mesylate, to ensure safe and effective use of the medication.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Liu Qian, Zan Mengqing, Huang Hanhan, Su Hai, Zhang Wenjing, Ma Lingyun, Zhang Guangchao, Zhang Zunjian, et al.. Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography. Asian Journal of Pharmaceutical Sciences 2024. DOI: 10.1016/j.ajps.2024.100966. PMID: 39640054. PMCID: PMC11617939.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]